{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:40:50Z","timestamp":1793144450670,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:p>\n            Serum uric acid (UA) has been implicated in the pathogenesis of hypertension. We investigated the relationship of serum UA to hypertension incidence and blood pressure (BP) progression in 3329 Framingham Study participants (mean age 48.7 years; 55.6% women) free of hypertension, myocardial infarction, heart failure, renal failure, or gout. At follow-up 4 years from baseline, 458 persons (13.8%) had developed hypertension, and 1201 persons (36.1%) had experienced progression to a higher BP stage. Age- and sex-adjusted rates of hypertension incidence increased progressively from 9.8% for the lowest quartile to 15.6% for the top quartile of serum UA; BP progression rates increased from 32.8% (lowest quartile) to 39.6% (top quartile). In multivariable analyses adjusting for age, sex, body mass index, diabetes, smoking, alcohol intake, serum creatinine, proteinuria, glomerular filtration rate, baseline BP, and interim weight change, a 1 SD higher serum UA was associated with an odds ratio (OR) of 1.17 (95% confidence interval [CI], 1.02 to 1.33) for developing hypertension, and an OR of 1.11 (95% CI, 1.01 to 1.23) for BP progression. In analyses of a subsample of 3157 individuals not on antihypertensive treatment at the follow-up examination, serum UA was positively associated with changes in systolic (\n            <jats:italic>P<\/jats:italic>\n            =0.02) and diastolic pressure 4 years later (\n            <jats:italic>P<\/jats:italic>\n            =0.04). In summary, serum UA level was an independent predictor of hypertension incidence and longitudinal BP progression at short-term follow-up in our community-based sample.\n          <\/jats:p>","DOI":"10.1161\/01.hyp.0000150784.92944.9a","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T01:25:04Z","timestamp":1101777904000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":367,"title":["Relations of Serum Uric Acid to Longitudinal Blood Pressure Tracking and Hypertension Incidence"],"prefix":"10.1161","volume":"45","author":[{"given":"Johan","family":"Sundstro\u0308m","sequence":"first","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sullivan","sequence":"additional","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph B.","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Levy","sequence":"additional","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Kannel","sequence":"additional","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[{"name":"From the Framingham Heart Study (J.S., L.S., R.B.D., D.L., W.B.K., R.S.V.), Framingham, Mass; the National Heart, Lung, and Blood Institute (D.L.); the Department of Mathematics (L.S., R.B.D.), Boston University, Mass; and the Department of Preventive Medicine (D.L., R.S.V.), Cardiology Section (R.S.V.), Boston University School of Medicine, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113787"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(89)90061-9"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.18.2404"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-1-199907060-00003"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.2.147"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.34.1.144"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200018080-00021"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.36.6.1072"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.5.1101"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)93017-6"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.2.577"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00283.2001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196609012750902"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000069700.62727.c5"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113972"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1973.03650090077014"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000085858.66548.59"},{"key":"e_1_3_2_18_2","first-page":"677","volume":"8","year":"1994","unstructured":"Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M. Serum uric acid and hypertension: the Olivetti Heart Study. J Hum Hypertens. 1994; 8: 677\u2013681.","journal-title":"J Hum Hypertens"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a115593"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(72)90331-6"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024600905574"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.17.6.969"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000091371.53502.d3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.41.3.279"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112813"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_3_2_27_2","first-page":"151","volume":"17","year":"1999","unstructured":"1999 World Health Organization\u2013International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens. 1999; 17: 151\u2013183.","journal-title":"J Hypertens"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.1.1"},{"key":"e_1_3_2_29_2","unstructured":"Kannel WB Wolf PA Garrison RJ. The Framingham Study: An epidemiological investigation of cardiovascular disease. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Framingham Heart Study 30-Year Follow-Up. Bethesda Md. NIH Publication No. 87-2703; 1987: 1\u2013462."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/10.9.838"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06710-1"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.29865"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.7.844"},{"key":"e_1_3_2_34_2","unstructured":"SAS\/STAT User\u2019s Guide. Version 8. Cary NC: SAS Institute Inc.; 1999."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010013"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011078"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00163854"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/93.11.707"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000150784.92944.9a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:48:38Z","timestamp":1715532518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000150784.92944.9a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1161\/01.HYP.0000150784.92944.9a"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000150784.92944.9a","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"2004-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}